 a 2year survival of 35%.311 Thus, for a patient with high operative risk and shortened life expectancy, rupture risk
must be high for beneÔ¨Åt to be obtained from EVAR.
We suggest informing patients contemplating open repair or
EVAR of their VQI perioperative mortality risk score.
Level of recommendation

2 (Weak)

Quality of evidence

C (Low)

EVAR
EVAR has rapidly expanded as the preferred approach
for treatment of AAA since